Citigroup Inc Hcw Biologics Inc. Transaction History
Citigroup Inc
- $190 Billion
- Q1 2025
A detailed history of Citigroup Inc transactions in Hcw Biologics Inc. stock. As of the latest transaction made, Citigroup Inc holds 14,047 shares of HCWB stock, worth $108,583. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,047Holding current value
$108,583% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HCWB
# of Institutions
16Shares Held
1.16MCall Options Held
0Put Options Held
0-
Avantax Planning Partners, Inc.280KShares$2.16 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA243KShares$1.88 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA237KShares$1.83 Million0.0% of portfolio
-
Cresset Asset Management, LLC Chicago, IL132KShares$1.02 Million0.01% of portfolio
-
Pullen Investment Management, LLC Bradenton, FL75.1KShares$580,6460.01% of portfolio
About HCW Biologics Inc.
- Ticker HCWB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,833,100
- Market Cap $277M
- Description
- HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal...